Olaparib in Epithelial Ovarian Cancer
Paula J. Anastasia, RN, MN, AOCN®
Cedars-Sinai Medical Center, Los Angeles, California
Author’s disclosure of potential conflicts of interest are found at the end of this article.
Correspondence to: Paula J. Anastasia, RN, MS, AOCN®, Cedars-Sinai Medical Center, 8700 Beverly Blvd., Los Angeles, CA 90048.
J Adv Pract Oncol 2016;7:756–761 |
© 2016 Harborside Press®
For access to the full length article, please sign in